Onyx Pharmaceuticals to Present at BIO CEO & Investor Conference
Emeryville, CA — Feb. 17, 2005
Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced that it will present at the BIO CEO & Investor conference on Wednesday, February 23, at 11:00 a.m. Eastern Time. Interested parties may access a live webcast of the presentation at:
http://www.corporate-ir.net/ireye/confLobby.zhtml?ticker=ONXX&item_id=1009071
It is recommended that listeners log on 15 minutes early in order to register and download any necessary software. If you are unable to participate during the live webcast, a recorded replay of the presentation will be available within 24 hours of the completion of the presentation through March 23, 2005.
Onyx Pharmaceuticals is engaged in the development of novel cancer therapies that target the molecular basis of cancer. With its collaborators, the company is developing small molecule drugs, including BAY 43-9006 with Bayer Pharmaceuticals Corporation. For more information about Onyx’s pipeline and activities, visit the company’s website at www.onyx pharm.com.
Back to 2005 Press Releases
